Anti-CD14 antibody [4B4F12],Abcam,AB182032

What is this antibody validated in? Anti-CD14 antibody [4B4F12] (ab182032) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human, Mouse samples. What is the molecular weight of CD14? Anti-CD14 [4B4F12] (ab182032) specifically detects a band for CD14 (UniProt: P08571) at a molecular weight of 40kDa. Trusted by the scientific community Anti-CD14 [4B4F12] (ab182032) was first used in a scientific publication in 2013 and has been cited over 30 times in peer-reviewed journals.

Host

Mouse

Reactivity

Mouse, Human

Application

IHC-P, Flow Cyt, WB

Platform ID

BAB058082665

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-CD14 antibody [4B4F12]
Cat. No.AB182032
HostMouse
IsotypeIgG1
ReactivityMouse, Human
ApplicationIHC-P, Flow Cyt, WB
ClonalityMonoclonal
Clone Number4B4F12
Concentration1 mg/mL Batch dependent concentration
ImmunogenRecombinant Fragment Protein within Human CD14 aa 1-250. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein G
Appearance/FormLiquid
ShippingBlue Ice
FormulationPreservative: 0.05% Sodium azide Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Coreceptor for bacterial lipopolysaccharide (PubMed : 1698311, PubMed : 23264655). In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed : 20133493, PubMed : 22265692, PubMed : 23264655). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed : 8612135). Acts as a coreceptor for TLR2 : TLR6 heterodimer in response to diacylated lipopeptides and for TLR2 : TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway (PubMed : 16880211). Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-) (PubMed : 23880187). See full target information CD14

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.